NO872659L - Farmastiske preparater med galaktitol som brer. - Google Patents
Farmastiske preparater med galaktitol som brer.Info
- Publication number
- NO872659L NO872659L NO872659A NO872659A NO872659L NO 872659 L NO872659 L NO 872659L NO 872659 A NO872659 A NO 872659A NO 872659 A NO872659 A NO 872659A NO 872659 L NO872659 L NO 872659L
- Authority
- NO
- Norway
- Prior art keywords
- galactitol
- weight
- parts
- water
- pharmaceuticals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/879,143 US4797388A (en) | 1984-05-21 | 1986-06-26 | Pharmaceutical compositions with galactitol as carrier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO872659D0 NO872659D0 (no) | 1987-06-25 |
| NO872659L true NO872659L (no) | 1987-12-28 |
Family
ID=25373508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO872659A NO872659L (no) | 1986-06-26 | 1987-06-25 | Farmastiske preparater med galaktitol som brer. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4797388A (de) |
| EP (1) | EP0251657B1 (de) |
| JP (1) | JPS6322527A (de) |
| AT (1) | ATE68978T1 (de) |
| AU (1) | AU599111B2 (de) |
| DE (1) | DE3774192D1 (de) |
| DK (1) | DK330787A (de) |
| FI (1) | FI872831L (de) |
| NO (1) | NO872659L (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE58900183D1 (de) * | 1988-03-19 | 1991-08-29 | Asta Pharma Ag | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. |
| US5215743A (en) * | 1988-04-13 | 1993-06-01 | Maninder Singh | Tumor necrosis factor formulations |
| US5141925A (en) * | 1990-04-23 | 1992-08-25 | Trustees Of Tufts College | Vivo methods for treating coccidiosis |
| GB2271281A (en) * | 1992-10-09 | 1994-04-13 | Orion Yhtymae Oy | Stabilised cyclophosphamide compositions |
| US6160165A (en) | 1998-12-10 | 2000-12-12 | Aesgen, Inc. | Method for preparation of disodium pamidronate |
| US6794536B1 (en) | 1998-12-10 | 2004-09-21 | Aesqen, Inc. | Method for preparation of disodium pamidronate |
| PE20021017A1 (es) * | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
| CA2347330C (en) * | 2001-05-10 | 2002-03-12 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
| US6613927B1 (en) | 2002-02-08 | 2003-09-02 | American Pharmaceutical Partners, Inc. | Sterile lyophilized ifosfamide and associated methods |
| CN100375622C (zh) * | 2003-11-25 | 2008-03-19 | 范敏华 | 一种氟尿嘧啶冻干粉针剂及其制备方法 |
| WO2006089002A2 (en) * | 2005-02-15 | 2006-08-24 | Yale University | Method for high throughput screening for antibodies and proteins inducing apoptosis |
| WO2007092178A1 (en) * | 2006-02-10 | 2007-08-16 | Amgen Inc. | Hydrate forms of amg706 |
| US10149857B2 (en) | 2017-03-09 | 2018-12-11 | Ampac Fine Chemicals Llc | Lyophilized cyclophosphamide composition and methods of preparation thereof |
| CN112533591A (zh) | 2018-08-03 | 2021-03-19 | 上海宣泰医药科技股份有限公司 | 一种水化环磷酰胺冻干组合物的方法及其产品 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1079397A (en) * | 1965-01-13 | 1967-08-16 | Chinoin Gyogyszer Es Vegyeszet | 1,6-dibromo-1,6-dideoxy dulcitol and pharmaceutical compositions containing it |
| US3384546A (en) * | 1965-05-28 | 1968-05-21 | Miles Lab | Directly compressed low-density crystalline sorbitol pharmaceutical tablets |
| US3944625A (en) * | 1973-02-02 | 1976-03-16 | Georgia-Pacific Corporation | Separation of mannitol from galactitol |
| FI53651C (fi) * | 1976-06-24 | 1979-05-15 | Farmos Oy | Fodervitaminloesning eller -emulsion |
| JPS5920647B2 (ja) * | 1976-10-01 | 1984-05-15 | 武田薬品工業株式会社 | 注射剤 |
| JPS56127321A (en) * | 1980-03-10 | 1981-10-06 | Mochida Pharmaceut Co Ltd | Preparation of gamma-globulin pharmaceutical |
| JPS5711909A (en) * | 1980-06-23 | 1982-01-21 | Shionogi & Co Ltd | Stable freeze-dried preparation of beta-lactam |
| JPS5874617A (ja) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | 人由来血液凝固第7因子含有水溶液の加熱処理方法 |
| DE3273597D1 (en) * | 1981-11-28 | 1986-11-06 | Sunstar Kk | Pharmaceutical composition containing interferon in stable state |
| IT1151126B (it) * | 1982-03-30 | 1986-12-17 | Pirelli | Procedimento e apparecchiatura per la fabbricazione di pneumatici |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
| EP0133767B1 (de) * | 1983-08-04 | 1991-04-03 | The Green Cross Corporation | Gamma-Interferonzusammensetzung |
| JPH0651641B2 (ja) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | ガンマ・インターフェロン組成物 |
| US4659699A (en) * | 1983-08-22 | 1987-04-21 | Cetus-Ben Venue Therapeutics | Process for freeze drying cyclophosphamide |
| JPS60190711A (ja) * | 1984-03-09 | 1985-09-28 | Tokyo Tanabe Co Ltd | プロトポルフイリン類注射用製剤 |
| US4604377A (en) * | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
| EP0225581A3 (de) * | 1985-11-30 | 1989-05-24 | Green Cross Corporation | Verfahren zur Hitzebehandlung von Immunoglobulinen und Immunoglobulinprodukt |
-
1986
- 1986-06-26 US US06/879,143 patent/US4797388A/en not_active Expired - Fee Related
-
1987
- 1987-06-23 AT AT87305579T patent/ATE68978T1/de active
- 1987-06-23 EP EP87305579A patent/EP0251657B1/de not_active Expired - Lifetime
- 1987-06-23 DE DE8787305579T patent/DE3774192D1/de not_active Expired - Lifetime
- 1987-06-25 NO NO872659A patent/NO872659L/no unknown
- 1987-06-25 AU AU74702/87A patent/AU599111B2/en not_active Ceased
- 1987-06-26 FI FI872831A patent/FI872831L/fi not_active Application Discontinuation
- 1987-06-26 JP JP62157947A patent/JPS6322527A/ja active Pending
- 1987-06-26 DK DK330787A patent/DK330787A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI872831A0 (fi) | 1987-06-26 |
| AU7470287A (en) | 1988-01-07 |
| DK330787D0 (da) | 1987-06-26 |
| EP0251657A2 (de) | 1988-01-07 |
| FI872831A7 (fi) | 1987-12-27 |
| ATE68978T1 (de) | 1991-11-15 |
| US4797388A (en) | 1989-01-10 |
| EP0251657B1 (de) | 1991-10-30 |
| NO872659D0 (no) | 1987-06-25 |
| FI872831L (fi) | 1987-12-27 |
| DE3774192D1 (de) | 1991-12-05 |
| EP0251657A3 (en) | 1988-06-22 |
| DK330787A (da) | 1987-12-27 |
| JPS6322527A (ja) | 1988-01-30 |
| AU599111B2 (en) | 1990-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO872659L (no) | Farmastiske preparater med galaktitol som brer. | |
| DK0395329T3 (da) | Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| DE3688114D1 (de) | Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate. | |
| ATE84032T1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| ATE76747T1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| DE69223914D1 (de) | 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate | |
| BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
| FR2679906B1 (fr) | Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| PT89802A (pt) | Processo para a preparacao de uma composicao farmaceutica, contendo o factor xiii de coagulacao do sangue humano, para a prevencao da hemorragia intraventricular em criancas permaturas | |
| PT90308A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa | |
| SE8600658D0 (sv) | Novel composition of matter | |
| ES2198424T3 (es) | Soluciones inyectables listas para el empleo que contienen doxorrubicina. | |
| GR3002765T3 (en) | New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient | |
| DE3866198D1 (de) | Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen. | |
| ATE2746T1 (de) | Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ES2036539T3 (es) | Un procedimiento para preparar derivados de ergolina. | |
| DE68920900D1 (de) | Prourokinasederivate mit niedrigem Molekulargewicht und sie enthaltende pharmazeutische Zusammensetzungen. | |
| ITMI911845A1 (it) | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. | |
| ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
| FI810643L (fi) | I 10-staellning substituerade 5-cyanmetylendibenzo /a d/ cyklohepten foerfarande foer deras framstaellning och terapeutiska medel innehaollande dem |